/Companies

Totus Medicines

27 employees on LinkedIn · 3 known investors

Find your way into Totus Medicines

Totus Medicines is a biopharmaceutical company developing small molecule drugs to address untreatable diseases by combining approaches in molecular design, structural biology, genetics, and cell biology. The company focuses on oncology and other therapeutic areas for patients with currently incurable conditions.

Founders & leadership

ND
Neil Dhawan, PhDCo-Founder
NUNassim Usman, PhD
Nassim Usman, PhDCEO and President

Investors · 3

DCVC (Data Collective)listed by DCVC (Data Collective)Palo Alto · $5M – $25M

How we know: a partner's Signal profile · the VCSheet dataset · Not right? Tell us

DCVC BioreportedPalo Alto

How we know: a partner's Signal profile · funding news · Not right? Tell us

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

Frequently asked questions

What does Totus Medicines do?
Totus Medicines is a biopharmaceutical company developing small molecule drugs to address untreatable diseases by combining approaches in molecular design, structural biology, genetics, and cell biology. The company focuses on oncology and other therapeutic areas for patients with currently incurable conditions.
Who founded Totus Medicines?
Totus Medicines was founded by Neil Dhawan, PhD.
Who are Totus Medicines's investors?
Totus Medicines's investors include DCVC (Data Collective), DCVC Bio, Social Impact Capital.